Abstract

BackgroundIt is known that mitochondria play an important role in certain cancers (prostate, renal, breast, or colorectal) and coronary disease. These organelles play an essential role in apoptosis and the production of reactive oxygen species; in addition, mtDNA also reveals the history of populations and ancient human migration. All these events and variations in the mitochondrial genome are thought to cause some cancers, including prostate cancer, and also help us to group individuals into common origin groups. The aim of the present study is to analyze the different haplogroups and variations in the sequence in the mitochondrial genome of a southern European population consisting of subjects affected (n = 239) and non-affected (n = 150) by sporadic prostate cancer.Methodology and Principal FindingsUsing primer extension analysis and DNA sequencing, we identified the nine major European haplogroups and CR polymorphisms. The frequencies of the haplogroups did not differ between patients and control cohorts, whereas the CR polymorphism T16356C was significantly higher in patients with PC compared to the controls (p = 0.029). PSA, staging, and Gleason score were associated with none of the nine major European haplogroups. The CR polymorphisms G16129A (p = 0.007) and T16224C (p = 0.022) were significantly associated with Gleason score, whereas T16311C (p = 0.046) was linked with T-stage.Conclusions and SignificanceOur results do not suggest that mtDNA haplogroups could be involved in sporadic prostate cancer etiology and pathogenesis as previous studies performed in middle Europe population. Although some significant associations have been obtained in studying CR polymorphisms, further studies should be performed to validate these results.

Highlights

  • Prostate cancer is one of the most prevalent cancers diagnosed in men

  • Our results do not suggest that mitochondrial DNA (mtDNA) haplogroups could be involved in sporadic prostate cancer etiology and pathogenesis as previous studies performed in middle Europe population

  • Some significant associations have been obtained in studying CR polymorphisms, further studies should be performed to validate these results

Read more

Summary

Introduction

Prostate cancer is one of the most prevalent cancers diagnosed in men. Prostate cancer incidence is characterised by a large geographic variability, ranging from few cases (approximately 4–7 per 100,000) in Asian countries to 70–100 cases per 100,000 in Nordic European countries and North America. It is known that mitochondria play an important role in certain cancers (prostate, renal, breast, or colorectal) and coronary disease These organelles play an essential role in apoptosis and the production of reactive oxygen species; in addition, mtDNA reveals the history of populations and ancient human migration. All these events and variations in the mitochondrial genome are thought to cause some cancers, including prostate cancer, and help us to group individuals into common origin groups. The aim of the present study is to analyze the different haplogroups and variations in the sequence in the mitochondrial genome of a southern European population consisting of subjects affected (n = 239) and non-affected (n = 150) by sporadic prostate cancer

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call